Navigation Links
DuPont Leader Highlights Strategy, Progress and Plans to Accelerate Growth in Advanced Materials and Discusses Near-Term Outlook

NEW YORK, March 5, 2015 /PRNewswire/ -- DuPont (NYSE: DD) announced that at the J.P. Morgan Aviation, Transportation and Industrials Conference held today in New York, DuPont Executive Vice President Matthew L. Trerotola discussed strategy, progress and plans to accelerate growth in the three Advanced Materials segments for DuPont.  Strengthening and growing the company's leading position in high-value advanced materials is one of the three areas of strategic priority for DuPont.

Discussing the company's Advanced Materials segments, Trerotola said, "We've made excellent progress in Performance Materials, Safety & Protection and Electronics & Communications.  Our bottom line earnings and operating margins have increased, and we are committed to further improvements. Moving forward, we are driving to accelerate growth while expanding margins in support of the DuPont strategy to build a higher growth, higher value company."  

Mr. Trerotola highlighted the strong progress DuPont made across the company in 2014, including: further refining its portfolio with 10 strategic portfolio actions and the advancement of the anticipated mid-year spin-off of Chemours; increasing the company's cost reduction targets for its operational redesign to at least $1.3 billion by 2017 on an annual run-rate basis; and continuing the company's commitment to return significant capital to shareholders with $3.7 billion returned to shareholders through share repurchases and dividends in 2014 alone.

Mr. Trerotola also noted several factors the company and Advanced Materials segments are confronting that will have an impact on the first quarter, but expressed confidence in long-term performance: "As we noted before, 2015 will be a challenging economic environment as we face certain headwinds related to the strengthening of the U.S. dollar and the continued volatility in energy markets which impacts our Performance Materials segment.  In addition, the unplanned outage at our Chambers Works facility will challenge productivity and earnings in our Safety & Protection segment in the first quarter.  We are committed and confident in our ability to execute on our plans while remaining poised to capitalize on changing market conditions and growth opportunities."

In addition, Mr. Trerotola outlined how DuPont is strengthening and growing its leading positions in Advanced Materials: "Today, DuPont is focused on a $50 billion portion of a $500 billion potential market.  We believe we can accelerate our growth in the market space we are currently targeting while tapping into new market opportunities as our businesses execute against their strategies. These strategies include:  step-changing applications development; collaborating for maximum success in key markets and applications, and driving an advanced materials pipeline of major innovations that includes both traditional and bio-based materials. While we have made strong bottom line progress in our Advanced Materials segments, we believe these initiatives will help us drive faster top line growth while retaining strong operating leverage."  

"Our market relevance and integrated science are true competitive advantages for DuPont.  We use market-facing units, networks and strategic account management to maximize our relevance at key customers. Our business draws on leading science and engineering to bring integrated science solutions to the world.  Going forward, we see very exciting opportunities to bring renewables and bio-engineered materials into new and existing applications in our markets," concluded Trerotola.  

To view a full copy of today's presentation, visit the "Events & Presentations" page on the DuPont Investor Center.

DuPont (NYSE: DD) has been bringing world-class science and engineering to the global marketplace in the form of innovative products, materials, and services since 1802.  The company believes that by collaborating with customers, governments, NGOs, and thought leaders we can help find solutions to such global challenges as providing enough healthy food for people everywhere, decreasing dependence on fossil fuels, and protecting life and the environment.  For additional information about DuPont and its commitment to inclusive innovation, please visit

Forward-Looking Statements:  This news release contains forward-looking statements which may be identified by their use of words like "plans," "expects," "will," "believes," "intends," "estimates," "anticipates" or other words of similar meaning.  All statements that address expectations or projections about the future, including statements about the company's growth strategy, product development, regulatory approval, market position, anticipated benefits of acquisitions, outcome of contingencies, such as litigation and environmental matters, expenditures and financial results, are forward-looking statements.  Forward-looking statements are not guarantees of future performance and are based on certain assumptions and expectations of future events which may not be realized.  Forward-looking statements also involve risks and uncertainties, many of which are beyond the company's control.  Some of the important factors that could cause the company's actual results to differ materially from those projected in any such forward-looking statements are: fluctuations in energy and raw material prices; failure to develop and market new products and optimally manage product life cycles; ability to respond to market acceptance, rules, regulations and policies affecting products based on biotechnology; significant litigation and environmental matters; failure to appropriately manage process safety and product stewardship issues; changes in laws and regulations or political conditions; global economic and capital markets conditions, such as inflation, interest and currency exchange rates; business or supply disruptions; security threats, such as acts of sabotage, terrorism or war, weather events and natural disasters; ability to protect and enforce the company's intellectual property rights; successful integration of acquired businesses and separation of underperforming or non-strategic assets or businesses and successful completion of the proposed spinoff of the Performance Chemicals segment including ability to fully realize the expected benefits of the proposed spinoff.  The company undertakes no duty to update any forward-looking statements as a result of future developments or new information.

Copyright©2015 PR Newswire.
All rights reserved

Related biology technology :

1. DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments
2. DuPont Pioneer, Perdue AgriBusiness Announce Plans to Double Acreage for the 2015 Plenish® High Oleic Soybean Program
3. DuPont Named Top Employer by Science Magazine
4. SolarUS Collaborates with DuPont Tate & Lyle to Develop a New Improved Solar Thermal High-Performance Heat Transfer Fluid
5. DuPont Tate & Lyle Bio Products Appoints Skidmore Sales as Distributor for Zemea® USP
6. DuPont Pioneer to Build $35 Million Soybean Research Facility at Stine Haskell Research Center
7. DuPont Pioneer Names Neal Gutterson to Lead Agricultural Biotechnology
8. DuPont Tate & Lyle Bio Products Appoints Lipscomb Chemical as Distributor for Zemea® USP
9. DuPont Congratulates David Hula for Breaking Corn Yield World Record with Pioneer® Brand Hybrid P2088YHR in 2013 NCGA Corn Yield Contest
10. DuPont Named Top Employer by Science Magazine for the 6th Consecutive Year
11. DuPont Pioneer Drought Research Council Indicates Need for Collaboration, Objectivity and Funding
Post Your Comments:
(Date:3/27/2021)... ... March 24, 2021 , ... ... Life Sciences and Healthcare firms of all sizes, adds depth to its team ... specialist. Pardillo, who earned his doctorate in computational chemistry from Florida International University ...
(Date:3/27/2021)... ... March 24, 2021 , ... ABI Wellness, ... and reporting approach designed under CEO Mark Watson, today announced a webinar dedicated ... featuring guest speakers Dr. Cameron Clark, Neuropsychologist and Founder of Sharp Thinking, and ...
(Date:3/27/2021)... ... ... The Xtalks editorial team is pleased to announce the launch of the ... joined by editorial team members Ayesha Rashid, Sydney Perelmutter and Mira Nabulsi to discuss ... including insights from industry experts. , The Xtalks Life Science podcast will feature ...
(Date:3/23/2021)... Conn. (PRWEB) , ... March 23, 2021 , ... ... develops solutions for characterizing microbiome populations down to the strain level, recently unveiled ... applications. , Not all microbes are created equal: some are easy to ...
Breaking Biology Technology:
(Date:3/27/2021)... ... March 25, 2021 , ... Phlexglobal announced ... Planet Group, has selected Phlexglobal and its innovative regulatory SaaS software, PhlexSubmission, as ... a comprehensive review of five regulatory software companies, with the review team including ...
(Date:3/27/2021)... ... 25, 2021 , ... The 2021 Virtual Conference on Clinical Trial Supply-Europe ... More and more, clinical trial supply conferences are featuring speakers and forums that ... Asymmetrex’s founder and CEO, James L. Sherley, M.D., Ph.D., presented a talk ...
(Date:3/23/2021)... ... March 23, 2021 , ... G-CON Manufacturing (G-CON), the ... by Matica Biotechnology (Matica Bio), a contract development and manufacturing organization (CDMO) specializing ... the cleanroom build out for its new GMP production facility in College Station, ...
Breaking Biology News(10 mins):